Product Images Oxybutynin Chloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Oxybutynin Chloride NDC 10135-610 by Marlex Pharmaceuticals Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a not-available description as the given text does not provide enough information to generate a complete and meaningful description. It appears to be a partially incomplete and unrelated text content of some medication or treatment with some statistical values.*
This is a description of a medication called Oxybutynin Chloride Extended-Release Tablets, USP which is manufactured and distributed by Marlex Pharmaceuticals. It comes in a package of 100 tablets with each extended-release tablet containing 5mg of oxybutynin chloride. The usual dosage information can be found in the package insert. It needs to be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F) to maintain controlled room temperature. It should be protected from moisture and humidity. Made in the USA.*
This is a description of a medication with the NDC number 10135-0609-05. The medication contains 5mg of oxybutynin chloride in a controlled-release formulation. The usual dosage and other relevant information are included in the package insert. The medication is to be stored at 20° to 25°C and protected from moisture and humidity. It is manufactured and distributed by Marlex Pharmaceuticals, Inc. in New Castle, DE and is made in the USA. There are 500 tablets in the container and the price is not available.*
This is a medication with NDC 10135-0610-01 used to treat urinary incontinence. Each extended-release tablet contains 10mg of oxybutynin chloride USP in a controlled-release formulation. It is manufactured and distributed by Marlex Pharmaceuticals, Inc. Dosage information can be found in the package insert. The tablets should be stored in a dry place at room temperature, protected from moisture and humidity.*
Each tablet contains 10 mg of oxybutynin chloride, USP in a controlled-release formulation. See package insert for dosage information. The tablets should be stored at a temperature of 20° to 25°C (68° to 77°F) to avoid moisture and humidity. The medication is manufactured and distributed by Marlex Pharmaceuticals, Inc. in New Castle, DE 19720. This medication is available by prescription only and comes in a bottle of 500 tablets.*
This medication is Oxybutynin Chloride Extended-Release Tablet with 15mg strength. It is manufactured and distributed by Marlex Pharmaceuticals, Inc. with the prescription of a physician. The medication is for oral use only, and each tablet contains 15mg of oxybutynin. Patients must follow the instructions in the package insert for the appropriate dosage. Store this medication at a temperature between 20°C to 25°C, with permitted excursions to 15°C to 30°C, and protect from moisture and humidity. The medication is made in the USA.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.